Achieve Life Sciences, Inc. Litigation Settlement, Expense
Achieve Life Sciences, Inc. (ACHV) reported Litigation Settlement, Expense of $1.38 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2017-07-31
- Achieve Life Sciences, Inc. litigation settlement, expense for the quarter ending 2016-12-31 was $0.00.
- Achieve Life Sciences, Inc. litigation settlement, expense for the quarter ending 2016-09-30 was $0.00.
- Achieve Life Sciences, Inc. litigation settlement, expense for the quarter ending 2016-06-30 was $1.38M.
- Achieve Life Sciences, Inc. litigation settlement, expense for fiscal 2016 was $1.38M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $1.38M derived: sum of 3 quarters · filed 2017-07-31 | $1.38M 10-K · filed 2017-02-23 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.38M derived: sum of 2 quarters · filed 2017-07-31 | $1.38M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.38M 10-Q · filed 2017-07-31 | $1.38M 10-Q · filed 2017-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |